However, rodent models of rhabdomyolysis are well established and could be used to investigate, whether a therapeutic time window exists, when activation of HDAC activity or the NF-κB pathway might stimulate the repair process and avoid loss of kidney function. The gene discussed is NFKB1; the disease is rhabdomyolysis.